China Housing & Land Development, Inc. (CHLN) [Rocket]

Overview

China Housing & Land Development, Inc. (CHLN)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
03/03/2016	SC 13E3/A	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
02/18/2016	8-K	Quarterly results
01/29/2016	8-K	Other Events, Financial Statements and Exhibits
12/30/2015	8-K	Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
12/24/2015	8-K	Other Events, Financial Statements and Exhibits
12/24/2015	DEFA14A	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/25/2015	DEF 14A	Form DEF 14A - Other definitive proxy statements

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07
Revenues	138.7	190.0	0.0	120.8	140.9	-7.6	26.5	73.9
Revenue growth	-27.0%		-100.0%	-14.3%	-1954.6%	-128.7%	-64.2%	36.6%
Cost of goods sold	131.2	146.2	0.0	102.5	109.7	-65.2	21.5	43.2
Gross profit	7.5	43.8	0.0	18.3	31.2	57.6	5.0	30.7
Gross margin	5.4%	23.1%		15.2%	22.2%	-758.7%	18.9%	41.5%
Selling, general and administrative	17.4	17.0	0.0	13.0	12.9	9.2	8.5	2.9
EBITA	-3.0	32.4	0.0	12.4	38.6	8.5	-9.8	26.1
EBITA margin	-2.2%	17.0%		10.2%	27.4%	-112.1%	-37.1%	35.3%
Amortization of intangibles	18.5	13.5		0.2	0.2
EBIT	-21.5	18.9	0.0	12.2	38.4	8.5	-9.8	26.1
EBIT margin	-15.5%	9.9%		10.1%	27.2%	-112.1%	-37.1%	35.3%
Pre-tax income	-20.3	16.7	0.0	16.1	26.2	0.9	8.8	16.7
Income taxes	1.2	4.9	0.0	11.2	18.5	-1.6	0.0	0.0
Tax rate		29.4%		69.5%	70.7%		0.0%	0.0%
Net income	-21.5	11.8	0.0	12.4	-28.9	2.5	8.8	16.7
Net margin	-15.5%	6.2%		10.2%	-20.5%	-32.5%	33.2%	22.6%

Diluted EPS	($0.62)	$0.33	$0.00	$0.34	($0.81)	$0.08	$0.28	$0.62
Shares outstanding (diluted)	34.7	35.1	36.5	36.4	35.6	31.2	31.4	26.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.